Suppr超能文献

干扰素诱导跨膜蛋白 3 基因 rs12252 多态性对 COVID-19 死亡率的影响。

Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortality.

机构信息

Department of Physiology, School of Medicine, Ilam University of Medical Science, Ilam, Iran.

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.

出版信息

Cytokine. 2022 Sep;157:155957. doi: 10.1016/j.cyto.2022.155957. Epub 2022 Jul 2.

Abstract

BACKGROUND AND AIMS

Interferon-induced transmembrane protein 3 (IFITM3) plays a critical role in the adaptive and innate immune response by preventing membrane hemifusion between the host and viral cell cytoplasm. This study aimed to evaluate whether IFITM3 rs12252 polymorphism is related to an increased mortality rate of coronavirus disease 2019 (COVID-19).

METHODS

The IFITM3 rs12252 polymorphism was genotyped using the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) in 548 dead and 630 improved patients positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

RESULTS

In the present study, the minor allele frequency of IFITM3 rs12252 (C) was significantly more frequent in dead patients than in improved cases. The results of the multivariate logistic regression analysis indicated that the lower lipid profiles, PCR Ct value, 25-hydroxyvitamin D, and uric acid and higher levels of erythrocyte sedimentation rate (ESR), liver enzymes, and creatinine, and IFITM3 rs12252 CC genotypes were related to the COVID-19 infection mortality.

CONCLUSIONS

In summary, our findings suggested a possible link between the mortality of COVID-19 infection, the CC genotypes of IFITM3 rs12252, and clinical parameters. Further investigations are required worldwide to prove the link relationship of COVID-19 mortality with host genetic factors.

摘要

背景与目的

干扰素诱导跨膜蛋白 3(IFITM3)通过阻止宿主与病毒细胞质之间的膜半融合,在适应性和先天免疫反应中发挥关键作用。本研究旨在评估 IFITM3 rs12252 多态性是否与 2019 年冠状病毒病(COVID-19)死亡率增加有关。

方法

使用扩增受阻突变系统-聚合酶链反应(ARMS-PCR)对 548 名死亡和 630 名改善的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)阳性患者的 IFITM3 rs12252 多态性进行基因分型。

结果

在本研究中,IFITM3 rs12252(C)的次要等位基因频率在死亡患者中明显高于改善病例。多变量逻辑回归分析的结果表明,较低的血脂谱、PCR Ct 值、25-羟维生素 D、尿酸水平以及较高的红细胞沉降率(ESR)、肝酶和肌酐水平,以及 IFITM3 rs12252 CC 基因型与 COVID-19 感染死亡率有关。

结论

综上所述,我们的研究结果表明,COVID-19 感染死亡率、IFITM3 rs12252 的 CC 基因型与临床参数之间可能存在关联。需要在全球范围内进行进一步的研究,以证明 COVID-19 死亡率与宿主遗传因素之间的关联关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f9/9250290/37f2ce077ca7/gr1_lrg.jpg

相似文献

1
Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortality.
Cytokine. 2022 Sep;157:155957. doi: 10.1016/j.cyto.2022.155957. Epub 2022 Jul 2.
2
The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19.
Cytokine. 2021 Jun;142:155492. doi: 10.1016/j.cyto.2021.155492. Epub 2021 Mar 6.
4
Interferon-Induced Transmembrane Protein 3 rs34481144 C/T Genotype and Clinical Parameters Related to Progression of COVID-19.
J Immunol Res. 2023 Jun 7;2023:2345062. doi: 10.1155/2023/2345062. eCollection 2023.
5
Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality.
Genomics. 2021 Jul;113(4):1733-1741. doi: 10.1016/j.ygeno.2021.04.002. Epub 2021 Apr 7.
7
The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19.
Cytokine. 2021 Jan;137:155354. doi: 10.1016/j.cyto.2020.155354. Epub 2020 Oct 23.
8
Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.
J Infect Dis. 2017 Jul 1;216(1):14-21. doi: 10.1093/infdis/jix242.
9
rs12252 polymorphism and coronavirus disease 2019 severity: A meta‑analysis.
Exp Ther Med. 2023 Feb 21;25(4):158. doi: 10.3892/etm.2023.11857. eCollection 2023 Apr.
10
The significance of IFITM3 polymorphism in COVID-19 asymptomatic and ICU admission Kurdish patients.
Cytokine. 2023 Nov;171:156349. doi: 10.1016/j.cyto.2023.156349. Epub 2023 Sep 6.

引用本文的文献

1
Research Progress into the Biological Functions of IFITM3.
Viruses. 2024 Sep 29;16(10):1543. doi: 10.3390/v16101543.
3
TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco.
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241257241. doi: 10.1177/03946320241257241.
4
Association of genetic polymorphisms with COVID-19 infection and outcomes: An updated meta-analysis based on 62 studies.
Heliyon. 2023 Dec 14;10(1):e23662. doi: 10.1016/j.heliyon.2023.e23662. eCollection 2024 Jan 15.
5
Increased expression of SCARF genes favoring SARS-CoV-2 infection in key target organs in CKD.
Clin Kidney J. 2023 Sep 5;16(12):2672-2682. doi: 10.1093/ckj/sfad220. eCollection 2023 Dec.
7
Interferon-Induced Transmembrane Protein 3 rs34481144 C/T Genotype and Clinical Parameters Related to Progression of COVID-19.
J Immunol Res. 2023 Jun 7;2023:2345062. doi: 10.1155/2023/2345062. eCollection 2023.
8
Genetic polymorphism between the Sorani and Hawrami kurdish populations and COVID-19 outcome.
Mol Biol Rep. 2023 Jun;50(6):5177-5183. doi: 10.1007/s11033-023-08448-8. Epub 2023 Apr 29.
9
Role of FokI rs2228570 and Tru9I rs757343 Polymorphisms in the Mortality of Patients Infected with Different Variants of SARS-CoV-2.
Arch Med Res. 2023 Jun;54(4):310-318. doi: 10.1016/j.arcmed.2023.03.006. Epub 2023 Mar 31.

本文引用的文献

2
Two-step fitness selection for intra-host variations in SARS-CoV-2.
Cell Rep. 2022 Jan 11;38(2):110205. doi: 10.1016/j.celrep.2021.110205. Epub 2021 Dec 16.
3
Association between the interferon-induced transmembrane protein 3 gene () rs34481144 / rs12252 haplotypes and COVID-19.
Curr Res Virol Sci. 2021;2:100016. doi: 10.1016/j.crviro.2021.100016. Epub 2021 Nov 29.
5
Uric acid as a prognostic factor and critical marker of COVID-19.
Sci Rep. 2021 Sep 7;11(1):17791. doi: 10.1038/s41598-021-96983-4.
6
Serum Uric Acid Concentrations and Risk of Adverse Outcomes in Patients With COVID-19.
Front Endocrinol (Lausanne). 2021 May 6;12:633767. doi: 10.3389/fendo.2021.633767. eCollection 2021.
7
Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19.
Eur J Med Genet. 2021 Jun;64(6):104227. doi: 10.1016/j.ejmg.2021.104227. Epub 2021 Apr 16.
8
Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality.
Genomics. 2021 Jul;113(4):1733-1741. doi: 10.1016/j.ygeno.2021.04.002. Epub 2021 Apr 7.
9
The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19.
Cytokine. 2021 Jun;142:155492. doi: 10.1016/j.cyto.2021.155492. Epub 2021 Mar 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验